Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Bridging analysis of the efficacy and safety of bazedoxifene in Japanese and global populations of postmenopausal women with osteoporosis.

Itabashi A, Yoh K, Chines AA, Miki T, Takada M, Sato H, Gorai I, Sugimoto T, Mizunuma H, Ochi H, Constantine GD, Ohta H.

J Bone Miner Metab. 2015 Jan;33(1):61-72. doi: 10.1007/s00774-013-0554-6. Epub 2014 Apr 9.

PMID:
24714934
2.

The Official Positions of the International Society for Clinical Densitometry: Indications of Use and Reporting of DXA for Body Composition.

Kendler DL, Borges JL, Fielding RA, Itabashi A, Krueger D, Mulligan K, Camargos BM, Sabowitz B, Wu CH, Yu EW, Shepherd J.

J Clin Densitom. 2013 Oct-Dec;16(4):496-507. doi: 10.1016/j.jocd.2013.08.020. Epub 2013 Oct 16. Review.

PMID:
24090645
3.

Once-Weekly Injection of Low-Dose Teriparatide (28.2 μg) Reduced the Risk of Vertebral Fracture in Patients with Primary Osteoporosis.

Fujita T, Fukunaga M, Itabashi A, Tsutani K, Nakamura T.

Calcif Tissue Int. 2014 Feb;94(2):170-5. doi: 10.1007/s00223-013-9777-8. Epub 2013 Aug 21.

4.

Consensus of official position of IOF/ISCD FRAX initiatives in Asia-Pacific region.

Wu CH, McCloskey EV, Lee JK, Itabashi A, Prince R, Yu W, Li-Yu J, Chionh SB, Zhao Y, Shin CS, Gunawan T, Tsai KS, Chieng PU, Changlai SP, Chan DC, Chen JF, Tanner SB, Hans DB, Kanis JA, Chang YF, Sun ZJ, Yang RS; Asia Pacific Panel of ISCD.

J Clin Densitom. 2014 Jan-Mar;17(1):150-5. doi: 10.1016/j.jocd.2013.06.002. Epub 2013 Jul 31.

PMID:
23916756
5.

Analysis of adipose tissues and stromal vascular cells in a murine arthritis model.

Hamaguchi K, Itabashi A, Kuroe Y, Nakano M, Fujimoto E, Kato T, Satoi K, Utsuyama M, Sato K.

Metabolism. 2012 Dec;61(12):1687-95. doi: 10.1016/j.metabol.2012.05.018. Epub 2012 Jul 4.

PMID:
22768996
6.

Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal Japanese women with osteoporosis.

Itabashi A, Yoh K, Chines AA, Miki T, Takada M, Sato H, Gorai I, Sugimoto T, Mizunuma H, Ochi H, Constantine GD, Ohta H.

J Bone Miner Res. 2011 Mar;26(3):519-29. doi: 10.1002/jbmr.252.

7.

International Society for Clinical Densitometry official positions: Asia-Pacific Region consensus.

Kung AW, Wu CH, Itabashi A, Lee JK, Park HM, Zhao Y, Chan WP, Kendler DL, Leib ES, Lewiecki EM, Bilezikian JP, Baim S; Asia Pacific Panel of ISCD.

J Clin Densitom. 2010 Oct-Dec;13(4):346-51. doi: 10.1016/j.jocd.2010.05.006. Epub 2010 Jul 21.

PMID:
20663696
8.

Design of a pragmatic approach to evaluate the effectiveness of concurrent treatment for the prevention of osteoporotic fractures: rationale, aims and organization of a Japanese Osteoporosis Intervention Trial (JOINT) initiated by the Research Group of Adequate Treatment of Osteoporosis (A-TOP).

Shiraki M, Kuroda T, Miyakawa N, Fujinawa N, Tanzawa K, Ishizuka A, Tanaka S, Tanaka Y, Hosoi T, Itoi E, Morimoto S, Itabashi A, Sugimoto T, Yamashita T, Gorai I, Mori S, Kishimoto H, Mizunuma H, Endo N, Nishizawa Y, Takaoka K, Ohashi Y, Ohta H, Fukunaga M, Nakamura T, Orimo H.

J Bone Miner Metab. 2011 Jan;29(1):37-43. doi: 10.1007/s00774-010-0188-x. Epub 2010 May 13.

PMID:
20461422
9.

Dose effects of oral estradiol on bone mineral density in Japanese women with osteoporosis.

Mizunuma H, Taketani Y, Ohta H, Honjo H, Gorai I, Itabashi A, Shiraki M.

Climacteric. 2010 Feb;13(1):72-83. doi: 10.3109/13697130902926910.

PMID:
19591010
10.

[Standardizing the diagnosis of acute ischemic stroke--the concept of an institutional manual and its clinical impact].

Shimizu H, Furui E, Shamoto H, Itabashi A, Matsumoto Y, Tominaga T.

Brain Nerve. 2009 May;61(5):581-9. Japanese.

PMID:
19514519
11.

A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis.

Hagino H, Nishizawa Y, Sone T, Morii H, Taketani Y, Nakamura T, Itabashi A, Mizunuma H, Ohashi Y, Shiraki M, Minamide T, Matsumoto T.

Bone. 2009 Jun;44(6):1078-84. doi: 10.1016/j.bone.2009.02.016. Epub 2009 Mar 2.

PMID:
19264155
12.
13.

Effects of pantothenic acid supplementation on adrenal steroid secretion from male rats.

Jaroenporn S, Yamamoto T, Itabashi A, Nakamura K, Azumano I, Watanabe G, Taya K.

Biol Pharm Bull. 2008 Jun;31(6):1205-8.

14.

Peripheral dual-energy X-ray absorptiometry in the management of osteoporosis: the 2007 ISCD Official Positions.

Hans DB, Shepherd JA, Schwartz EN, Reid DM, Blake GM, Fordham JN, Fuerst T, Hadji P, Itabashi A, Krieg MA, Lewiecki EM.

J Clin Densitom. 2008 Jan-Mar;11(1):188-206. doi: 10.1016/j.jocd.2007.12.012.

PMID:
18442759
15.

[HIP study--how to prevent hip fractures?].

Itabashi A.

Nihon Rinsho. 2007 Nov 28;65 Suppl 9:286-92. Review. Japanese. No abstract available.

PMID:
18159711
16.

Milk basic protein increases bone mineral density and improves bone metabolism in healthy young women.

Uenishi K, Ishida H, Toba Y, Aoe S, Itabashi A, Takada Y.

Osteoporos Int. 2007 Mar;18(3):385-90. Epub 2006 Oct 18.

PMID:
17048062
18.

Efficacy and tolerability of once-weekly administration of 17.5 mg risedronate in Japanese patients with involutional osteoporosis: a comparison with 2.5-mg once-daily dosage regimen.

Kishimoto H, Fukunaga M, Kushida K, Shiraki M, Itabashi A, Nawata H, Nakamura T, Ohta H, Takaoka K, Ohashi Y; Risedronate Phase III Research Group.

J Bone Miner Metab. 2006;24(5):405-13.

PMID:
16937274
19.

[Examination about utility of a Streptococcus pneumoniae capsular antigen swiftness search kit urine in a pneumonia patient].

Hashikita G, Yamaguti T, Tachi Y, Kishi E, Kawamura T, Takahashi S, Arai Y, Koyama S, Huruhata T, Itabashi A, Oka Y, Yamazaki T, Maesaki S.

Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi. 2005;16(2):153-61. Japanese.

PMID:
16536061
20.

Supplemental Content

Loading ...
Support Center